Project Submission No. S00497
Project Title 20 MW Solar Power Project by M/s Sun Pharmaceutical Industries Limited
Project Owner (as per PSF & LOA) Sun Pharmaceutical Industries Limited
Focal Point of Project Owners*(FP)
Sun Pharmaceutical Industries Limited
Email of Contact Person of FP (Primary)
Email of Contact Person of FP (Secondary)
Country India
Submission Date 28 Jun 2022
Global Stakeholder Consultation Period 10 Oct 2022 - 24 Oct 2022
Sector 1.Energy industries (renewable-/non-renewable sources)
GCC/CDM Methodology & Version GCCM001 Methodology for Renewable Energy Generation Projects Supplying Electricity to Grid or Captive Consumers & version 3.0
Forecasted GHG Emission Reduction(TCO2/Year) 29,941
Forecasted E+ Label Yes
Forecasted S+ Label Yes
Forecasted SDG+ Goals 5,7,8,13
Forecasted SDG+ Label Gold
Forecasted Market Eligibility CORSIA(C+)
Name of Authorized External Representative Organization
Name of Focal Point of External Representative
Email-id of Focal Point
Documents for Global Stakeholder Consultation Project Submision, Calculation Sheet, Other Documents
Project Brief

The project activity is the installation of a new captive grid-connected 20 MW Solar power plant at the site where no renewable power plant was operating prior to the implementation of the project activity (green-field plant). The project activity is solar power project which is being implemented by M/s Sun Pharmaceutical Industries Limited. The annual average estimated emission reductions from project activity are 29,941 tCO2e/annum.

Additional Information